Vaccine Stocks Surge Amid Avian Flu Outbreak: Market Impact and Investment Tips

Friday, 24 May 2024, 12:15

This week, vaccine stocks including Moderna, Novavax, and BioNTech rallied as avian flu was detected in humans in the U.S. and Australia, signaling a potential outbreak. Government discussions with vaccine companies and novel technologies indicate preparations for a possible vaccine program against the avian flu. However, while stock prices surged, the actual global impact on the economy from an avian flu outbreak remains uncertain.
https://store.livarava.com/3d95bfa5-19c8-11ef-a3d8-9d5fa15a64d8.jpg
Vaccine Stocks Surge Amid Avian Flu Outbreak: Market Impact and Investment Tips

Bird flu detected in Michigan and Australia in the first detections since March

A new avian flu, H5N1, was detected in cattle back in March, with one worker in Texas coming down with associated conjunctivitis at that time. But on Wednesday this week, a second U.S. dairy worker in Michigan tested positive for the avian flu as well. That same day, an Australian dairy worker also tested positive for avian flu, marking the first-ever human case of avian flu in that country.

The discoveries spurred fears of an outbreak.

That same day, the Assistant Secretary of Preparedness and Response at the Department of Health and Human Services, Dawn O'Connell, noted that Moderna and Pfizer, which partnered with BioNTech on the COVID-19 mRNA vaccine, were in talks over a potential mRNA vaccine program for the new avian flu.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe